Member of the Association of American Physicians
David R. Bangsberg focuses on Acquired immunodeficiency syndrome, Immunology, Internal medicine, Viral load and Public health. His Acquired immunodeficiency syndrome research includes themes of Mental health, Psychiatry, Cohort study and Environmental health. His studies deal with areas such as Pharmacotherapy and Drug resistance as well as Immunology.
In his study, Randomized controlled trial, Pill count and Medication monitoring is inextricably linked to Pill, which falls within the broad field of Internal medicine. His Viral load study also includes
His primary scientific interests are in Acquired immunodeficiency syndrome, Internal medicine, Immunology, Public health and Viral load. In his study, which falls under the umbrella issue of Acquired immunodeficiency syndrome, Logistic regression is strongly linked to Odds ratio. His Internal medicine study which covers Antiretroviral therapy that intersects with Pediatrics, Retrospective cohort study, Hiv infected and Pill.
His work deals with themes such as Pharmacotherapy and Drug resistance, which intersect with Immunology. The study incorporates disciplines such as Psychological intervention, Psychiatry, Developing country and Family medicine in addition to Public health. His work investigates the relationship between Psychological intervention and topics such as Randomized controlled trial that intersect with problems in Pre-exposure prophylaxis.
Psychological intervention, Internal medicine, Cohort, Antiretroviral therapy and Public health are his primary areas of study. His Internal medicine research is multidisciplinary, relying on both Nevirapine, Efavirenz and Viral load. His study in Viral load is interdisciplinary in nature, drawing from both Environmental health, Viremia, Acquired immunodeficiency syndrome, Confidence interval and Depression.
His study in Acquired immunodeficiency syndrome is interdisciplinary in nature, drawing from both Observational study, Logistic regression and Virology. His Cohort study incorporates themes from Pregnancy, Cohort study and Hazard ratio. His Antiretroviral therapy research is multidisciplinary, relying on both Immunology and First line.
David R. Bangsberg spends much of his time researching Cohort, Public health, Antiretroviral therapy, Clinical psychology and Internal medicine. David R. Bangsberg interconnects Adherence monitoring, Retrospective cohort study, Emergency medicine, Home visits and Comorbidity in the investigation of issues within Cohort. His studies examine the connections between Public health and genetics, as well as such issues in Young adult, with regards to Rural health, Mass screening, Norm, Human physical appearance and Acquired immunodeficiency syndrome.
David R. Bangsberg has included themes like Nevirapine, CD8 and Viral load in his Internal medicine study. His Viral load study necessitates a more in-depth grasp of Immunology. David R. Bangsberg works mostly in the field of Health psychology, limiting it down to concerns involving Health education and, occasionally, Family medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Jared M. Baeten;Deborah Donnell;Deborah Donnell;Patrick Ndase;Nelly R. Mugo;Nelly R. Mugo.
The New England Journal of Medicine (2012)
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F;Jia X;McLaren Pj.
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.
David R. Bangsberg;Frederick M. Hecht;Edwin D. Charlebois;Andrew R. Zolopa.
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
P Braitstein;Mwg Brinkhof;F Dabis;M Schechter.
The Lancet (2006)
Non-adherence to highly active antiretroviral therapy predicts progression to Aids
David R. Bangsberg;Sharon Perry;Edwin D. Charlebois;Richard A. Clark.
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.
Edward J. Mills;Jean B. Nachega;Jean B. Nachega;Iain Buchan;James Orbinski.
Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting : a randomized controlled trial of text message reminders
Cristian Pop-Eleches;Harsha Thirumurthy;Harsha Thirumurthy;James P. Habyarimana;Joshua G. Zivin.
Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators
Edward J. Mills;Jean B Nachega;David R Bangsberg;Sonal Singh.
PLOS Medicine (2006)
Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis
Ingrid T Katz;Ingrid T Katz;Annemarie E Ryu;Afiachukwu G Onuegbu;Christina Psaros.
Journal of the International AIDS Society (2013)
Less Than 95% Adherence to Nonnucleoside Reverse-Transcriptase Inhibitor Therapy Can Lead to Viral Suppression
David R. Bangsberg.
Clinical Infectious Diseases (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: